NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents
Excerpt:
...the pan-cancer cohort showed significantly increased sensitivity (p = 0.0198) to cisplatin for cell lines with NSD1 mutations (n = 18) compared to those with wild-type NSD1 (n = 798)...